Niaspan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
Conditions:   Atherogenic Dyslipidemia;   Obesity Associated Disorder Interventions:   Other: Therapeutic Lifestyle Changes;   Other: Placebo;   Drug: Fenofibrate;   Dietary Supplement: Wax Matrix Extended Release Niacin (WMER Niacin) Sponsors:   Lewai Sharki Abdulaziz, MSc PhD;   Al-Kindy College of Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2018 Category: Research Source Type: clinical trials